Burkina Faso vs Sao Tome and Principe: Statin use vs. average non-HDL cholesterol levels
Burkina Faso
2.6
in 2018
Sao Tome and Principe
2.7
in 2018
Burkina Faso rank
187th
Sao Tome and Principe rank
184th
Statin use vs. average non-HDL cholesterol levels over time
- Burkina Faso
- Sao Tome and Principe
How they compare
Sao Tome and Principe currently reports 2.7 against 2.6 in Burkina Faso, a difference of 0.1.
Across all 39 years both countries report, Sao Tome and Principe has been ahead every year.
Burkina Faso ranks 187th and Sao Tome and Principe ranks 184th of 191 countries.
Sao Tome and Principe has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burkina Faso | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.13 | 2.51 | 0.38 | Sao Tome and Principe |
| 1990s | 2.32 | 2.6 | 0.28 | Sao Tome and Principe |
| 2000s | 2.46 | 2.68 | 0.22 | Sao Tome and Principe |
| 2010s | 2.57 | 2.7 | 0.1333 | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Burkina Faso or Sao Tome and Principe?
- Sao Tome and Principe, at 2.7 against 2.6 in Burkina Faso as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Burkina Faso and Sao Tome and Principe?
- 0.1, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Burkina Faso and Sao Tome and Principe?
- 39 years are reported by both, from 1980 to 2018.
- How do Burkina Faso and Sao Tome and Principe rank globally for statin use vs. average non-hdl cholesterol levels?
- Burkina Faso ranks 187th and Sao Tome and Principe ranks 184th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.